Inhibitor Therapeutics, Inc. - FORM 10-K - EX-23.1 - EXHIBIT 23.1 - May 4, 2011

Attached files

file filename
10-K - FORM 10-K - Inhibitor Therapeutics, Inc.d10k.htm
EX-32.2 - EXHIBIT 32.2 - Inhibitor Therapeutics, Inc.dex322.htm
EX-13.1 - EXHIBIT 13.1 - Inhibitor Therapeutics, Inc.dex131.htm
EX-32.1 - EXHIBIT 32.1 - Inhibitor Therapeutics, Inc.dex321.htm
EX-31.1 - EXHIBIT 31.1 - Inhibitor Therapeutics, Inc.dex311.htm
EX-31.2 - EXHIBIT 31.2 - Inhibitor Therapeutics, Inc.dex312.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Annual Report on Form 10-K of Commonwealth Biotechnologies, Inc. for the years ended December 31, 2010 and 2009 of our report dated April 15, 2011 included in its Registration Statement on Form S-8 (No. 333-51074) and S-3 (No. 333-51078) relating to the financial statements for the years then.

LOGO

Witt Mares, PLC

Richmond, Virginia

April 15, 2011

Inhibitor Therapeutics, Inc. Reports